Cooley's anemia
Subtitle: ninth symposium
By: issue editors, Elliott P. Vichinsky and Ellis J. Neufeld
Contributors: Neufeld, Ellis Jacob; Vichinsky, Elliott P.
Series: Annals of the New York Academy of Sciences -- v. 1202; Annals of the New York Academy of Sciences -- v. 1202.
Publisher: Published by Blackwell Pub. on behalf of the New York Academy of Sciences
Published: 2010
Place of publication: Boston, Mass
Language: eng
Number of pages: 254
ISBN-13: 9781573317825
Subjects: Beta-Thalassemia; Congresses; Thalassemia
Description: "This volume presents manuscripts stemming from the 'Ninth Cooley's Anemia Symposium,' held October 21-24, 2009 at the New York Academy of Sciences, and sponsored by the Cooley's Anemia Foundation and the New York Academy of Sciences"--Contents p.
Notes: Caption title.

Includes bibliographical references.
Table of contents: title: Clinical trials in thalassemia: insights from the patient community; title: Pathogenesis and management of iron toxicity in thalassemia; title: The role of antioxidants and iron chelators in the treatment of oxidative stress in thalassemia; title: Thalassemia as a global health problem: recent progress toward its control in the developing countries; title: Iron metabolism and ineffective erythropoiesis in [beta]-thalassemia mouse models; title: Hepcidin in [beta]-thalassemia; title: Therapy for [beta]-globinopathies: a brief review and determinants for successful and safe correction; title: Humanized mouse models of Cooley's anemia: correct fetal-to-adult hemoglobin switching, disease onset, and disease pathology; title: Strategy for a multicenter phase I clinical trial to evaluate globin gene transfer in [beta]-thalassemia; title: Hematopoietic stem cell mobilization strategies for gene therapy of beta thalassemia and sickle cell disease; title: Transcriptional silencing of fetal hemoglobin by BCL11A; title: The challenge of obtaining therapeutic levels of genetically modified hematopoietic stem cells in [beta]-thalassemia patients; title: Deferiprone; title: Combined iron chelation therapy; title: Deferasirox: current knowledge and future challenges; title: Monitoring the efficiency of iron chelation therapy: the potential of nontransferrin-bound iron; title: Critical appraisal of growth retardation and pubertal disturbances in thalassemia; title: Magnetic resonance assessment of iron overload by separate measurement of tissue ferritin and hemosiderin iron; title: Predicting pituitary iron and endocrine dysfunction; title: Better survival and less cardiac morbidity in female patients with thalassemia major: a review of the literature; title: A preclinical approach for gene therapy of [beta]-thalassemia; title: The role of reduced intensity preparative regimens in patients with thalassemia given hematopoietic transplantation; title: Progress in hematopoietic stem cell transplantation as allogeneic cellular gene therapy in thalassemia; title: Emerging insights in the management of hemoglobin E beta thalassemia; title: Fetal globin gene inducers: novel agents and new potential; title: Detection of the cardiovascular complications of thalassemia by echocardiography; title: Cardiovascular MRI in thalassemia major; title: Complexity of alpha thalassemia: growing health problem with new approaches to screening, diagnosis, and therapy; title: Nutritional deficiencies in patients with thalassemia; title: Ferritin iron minerals are chelator targets, antioxidants, and coated, dietary iron; title: Pulmonary hypertension in thalassemia; title: The natural history of thalassemia intermedia; title: Hepcidin and Hfe in iron overload in [beta]-thalassemia; title: Fertility potential in thalassemia major women: current findings and future diagnostic tools; title: Redefining thalassemia as a hypercoagulable state; title: Treatment options for thalassemia patients with osteoporosis; title: Health care transition in thalassemia: pediatric to adult-oriented care; title: Ninth Cooley's Anemia Symposium: summary and perspective.